Compounds > 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
Page last updated: 2024-09-03

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Meningeal Neoplasms

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Meningeal Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Cappuzzo, J; Lipinski, L; Popoola, D; Prasad, D1
Bos, EM; Brabander, T; Bromberg, JEC; de Herder, WW; de Leeuw, RC; Dirven, CMF; Hofland, J; Konijnenberg, MW; Kros, JM; Minczeles, NS1
Albert, NL; Biczok, A; Bodensohn, R; Dekorsy, FJ; Forbrig, R; Niyazi, M; Quach, S; Schichor, C; Teske, N; Tonn, JC; Ueberschaer, M1

Other Studies

3 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Meningeal Neoplasms

ArticleYear
[
    BMJ case reports, 2022, Apr-29, Volume: 15, Issue:4

    Topics: Brain Ischemia; Craniotomy; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Ischemic Stroke; Meningeal Neoplasms; Meningioma; Radiopharmaceuticals; Radiosurgery; Stroke; Tomography, X-Ray Computed

2022
Efficacy and safety of peptide receptor radionuclide therapy with [
    European journal of nuclear medicine and molecular imaging, 2023, Volume: 50, Issue:4

    Topics: Humans; Meningeal Neoplasms; Meningioma; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Radioisotopes; Receptors, Peptide; Retrospective Studies

2023
Postoperative [
    European journal of nuclear medicine and molecular imaging, 2023, Volume: 51, Issue:1

    Topics: Female; Gallium Radioisotopes; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Prospective Studies; Retrospective Studies; World Health Organization

2023